All publications

Sort by: Date | Author | Title

Madsen, J., Elfving, B., Frøkjær, V. G., Kornum, B. R., Thomsen, G., Martiny, L. & Knudsen, G. M. (2011). Synthesis and biological evaluation of 125l/123l-labelled analogues of citalopram and escitalopram as potential radioligands for imaging of the serotonin transporter. Journal of Labelled Compounds and Radiopharmaceuticals, 54(4), 185-190.

Madsen, T., Buttenschøn, H. N., Uher, R., Behrendt-Møller, I., Perroud, N., Maier, W., Hauser, J., Dernovsek, M. Z., Henigsberg, N., Souery, D., Rietschel, M., McGuffin, P., Aitchison, K. J., Mors, O. & Köhler-Forsberg, O. (2019). Trajectories of Suicidal Ideation During 12 Weeks of Escitalopram or Nortriptyline Antidepressant Treatment Among 811 Patients With Major Depressive Disorder. The Journal of Clinical Psychiatry, 80(4), Article 18m12575. https://doi.org/10.4088/JCP.18m12575

Madsen, C. A., Navarro, M. L., Elfving, B., Kessing, L. V., Castrén, E., Mikkelsen, J. D. & Knudsen, G. M. (2024). The effect of antidepressant treatment on blood BDNF levels in depressed patients: A review and methodological recommendations for assessment of BDNF in blood. European Neuropsychopharmacology, 87, 35-55. https://doi.org/10.1016/j.euroneuro.2024.06.008

Madsen, J., Elfving, B., Andersen, K., Martiny, L. & Knudsen, G. M. (2004). Gas phase production of [¹¹C]methyl iodide-d₃. Synthesis and biological evaluation of S-[N-methyl-¹¹C]citalopram and deuterated analogues. Journal of Labelled Compounds and Radiopharmaceuticals, 47(6), 335-348. https://doi.org/10.1002/jlcr.820

Madsen, J. A. (2010). MRI Cerebral Morphometry: Tools for the study of neuro-degenerative diseases.

Madsen, M. M. L. (2008). Attitudes towards psychiatric genetics among future users and providers of psychiatric genetic testing and counselling. <Forlag uden navn>.

Lykke, J., Oestrich, I., Austin, S. & Hesse, M. (2010). The implementation and evaluation of cognitive milieu therapy for dual diagnosis inpatients: A pragmatic clinical trial. Mental Health and Substance Use, 6(1), 58-72. https://doi.org/10.1080/15504260903498763

Lundorf, M. D., Buttenschøn, H. N., Foldager, L., Blackwood, D. H., Muir, W. J., Murray, V., Pelosi, A. J., Kruse, T. A., Ewald, H. & Mors, O. (2005). Mutational screening and association study of glutamate decarboxylase 1 as a candidate susceptibility gene for bipolar affective disorder and schizophrenia. American Journal of Medical Genetics. Part B: Neuropsychiatric Genetics, 135(1), 94-101.

Lund, A. E. & Sinning, S. (2016). Jungle brew: Molecular pharmacology of harmala alkaloids on monoamine transporters. Poster session presented at Årsmøde for Dansk Selskab for Farmakologi, Toksikologi og Medicinalkemi, Sandbjerg, Denmark.

Lumertz, F. S., Kestering-Ferreira, E., Orso, R., Creutzberg, K. C., Tractenberg, S. G., Stocchero, B. A., Viola, T. W. & Grassi-Oliveira, R. (2022). Effects of early life stress on brain cytokines: A systematic review and meta-analysis of rodent studies. Neuroscience and Biobehavioral Reviews, 139, Article 104746. https://doi.org/10.1016/j.neubiorev.2022.104746

Lucas, G., Rymar, V. V., Du, J., Mnie-Filali, O., Bisgaard, C., Manta, S., Lambas-Senas, L., Wiborg, O., Haddjeri, N., Piñeyro, G., Sadikot, A. F. & Debonnel, G. (2007). Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action. Neuron, 55(5), 712-25. https://doi.org/10.1016/j.neuron.2007.07.041

Lou, H. O. C. & Jensen, K. (2011). GABAergic interneuron regulation of conscious experience - a hypothesis. Abstract from The Brain Prize Meeting, Aarhus, Denmark.

Loreto, B. B. L., Sordi, A. O., de Castro, M. N., Ornell, F., Guarnieri, E. P., Roza, T. H., Schuch, J. B., Cima, M. D. S., Pechansky, F., Grevet, E. H., Grassi-Oliveira, R., von Diemen, L. & Kessler, F. H. P. (2023). Proposing an integrative, dynamic and transdiagnostic model for addictions: dysregulation phenomena of the three main modes of the predostatic mind. Frontiers in Psychiatry, 14, Article 1298002. https://doi.org/10.3389/fpsyt.2023.1298002

Lønstrup, J., Buxbom, L. & Tehrani, E. (2008). Kvalitetssikring af ECT-behandling på Århus Universitetshospital, Risskov. Poster session presented at Psykiatriens 3. Forskningsdag, Risskov, Denmark.

Lønstrup, J., Buxbom, L. & Tehrani, E. (2011). Kvalitetssikring af ECT-behandling på Århus Universitetshospital, Risskov. Poster session presented at Psykiatriens 6. Forskningsdag, Risskov, Denmark.

Lomstein, B. A., Jørgensen, B. B., Schubert, C. J. & Niggemann, J. (2006). Amino acid biogeo- and stereochemistry in coastal Chilean sediments. Geochimica et Cosmochimica Acta, 70(12), 2970-2989.

Lolk, A., Andersen, K. & Rosenberg, R. (2013). Organiske psykiske lidelser (FO). In R. Rosenberg & P. Videbech (Eds.), Klinisk neuropsykiatri: Fra molekyle til sygdom (2. ed., pp. 235-277). FADL's Forlag.

Lisboa, S. F., Issy, A. C., Biojone, C., Montezuma, K., Fattori, V., Del-Bel, E. A., Guimarães, F. S., Cunha, F. Q., Verri, W. A. & Joca, S. R. L. (2018). Mice lacking interleukin-18 gene display behavioral changes in animal models of psychiatric disorders: Possible involvement of immunological mechanisms. Journal of Neuroimmunology, 314, 58-66. https://doi.org/10.1016/j.jneuroim.2017.11.008

Lisboa, S. F. S., Issy, A. C., Biojone, C., Montezuma, K., Fattori, V., Del-Bel, E. A., Guimaraes, F. S., Cunha, F. Q., Verri, W. A. & Joca, S. R. L. (2018). Mice lacking interleukin-18 gene display behavioral changes in animal models of psychiatric disorders: Possible involvement of immunological mechanisms. Journal of Neuroimmunology.

Linnet, K. (2002). EZ rules: Automatic Selection of Statistical Control Rules for Laboratory Tests. Clinical Chemistry, 48(3), 594-595.

Linnet, K. (2002). Glucuronidation of olanzapine by cDNA-expressed human UDP-glucuronosyltransferases and human liver microsomes. Human Psychopharmacology: Clinical and Experimental, 17, 233-238.

Linnet, K. & Olesen, O. V. (2002). Free and glucuronidated olanzapine serum concentrations in psychiatric patients: influence of carbamazepine comedication. Therapeutic Drug Monitoring, 24, 512-517.

Linnet, K. (2004). A review on the influence of the drug transporter P-glycoprotein on the distribution of drugs over the blood-brain barrier. Recent Res Devel Drug Metabol Dispos, 2, 15-25.

Linnet, K. (2004). An overview on the metabolism of frequently used antidepressants with focus on the role of cytochrome P450. Current Topics in Pharmacology, 8, 137-147.

Link, W. A., Ledo, F., Torres, B., Palczewska, M., Madsen, T. M., Savignac, M., Albar, J. P., Mellstrom, B. & Naranjo, J. R. (2004). Day-night changes in downstream regulatory element antagonist modulator/potassium channel interacting protein activity contribute to circadian gene expression in pineal gland. Journal of Neuroscience, 24(23), 5346-5355.

Lillethorup, T. P., Iversen, P., Fontain, J., Wegener, G., Doudet, D. J. & Landau, A. M. (2015). Electroconvulsive shocks decrease α2-adrenoceptor binding in the Flinders rat model of depression. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 404-412. https://doi.org/10.1016/j.euroneuro.2014.12.003

Lillethorup, T. P., Iversen, P., Wegener, G., Doudet, D. J. M. & Landau, A. M. (2015). α2-adrenoceptor binding in Flinders-sensitive line compared with Flinders-resistant line and Sprague-Dawley rats. Acta Neuropsychiatrica (Print), 1-8. https://doi.org/10.1017/neu.2015.24

Lillethorup, T. P., Glud, A. N., Sørensen, J. C. H., Landau, A. M., Jakobsen, S. & Jakobsen, S. (2015). Brain Serotonin Transporter Binding In a Minipig Model of Parkinson's Disease. Poster session presented at Brain & Brain PET 2015, Vancouver, Canada.

Lillethorup, T. P., GLUD, AN., Jakobsen, S., Alstrup, A. K. O., Moeller, A., Sørensen, J. C. H., Doudet, D. J. & Landau, A. M. (2017). Multi-Neurotransmitter Deficits in a Minipig Model of Parkinson’s Disease. Poster session presented at 1st Annual Research Meeting, Aarhus, Denmark.

Lillethorup, T. P., Glud, A. N., Alstrup, A. K. O., Mikkelsen, T. W., Nielsen, E. H. T., Zaer, H., Doudet, D. J., Brooks, D. J., Sørensen, J. C. H., Orlowski, D. & Landau, A. M. (2018). Nigrostriatal proteasome inhibition impairs dopamine neurotransmission and motor function in minipigs. Experimental Neurology, 303, 142-152. https://doi.org/10.1016/j.expneurol.2018.02.005

Lillethorup, T. P., GLUD, AN., Alstrup, A. K. O., Noer, O., Nielsen, E. H. T., Schacht, A. C., Landeck, N., Kirik, D., Orlowski, D., Sørensen, J. C. H., Doudet, D. J. & Landau, A. (2018). Longitudinal monoaminergic PET imaging of chronic proteasome inhibition in minipigs. Scientific Reports, 8(1), Article 15715. https://doi.org/10.1038/s41598-018-34084-5

Lillethorup, T. P., Glud, A. N., Landeck, N., Alstrup, A. K. O., Jakobsen, S., Vang, K., Doudet, D. J., Brooks, D. J., Kirik, D., Hinz, R., Sorensen, J. C. & Landau, A. M. (2018). In vivo quantification of glial activation in minipigs overexpressing human alpha-synuclein. Synapse, 72(12), Article 22060. https://doi.org/10.1002/syn.22060

Lillethorup, T. P., Noer, O., Alstrup, A. K. O., Cristiano Real Gregório, C., Stokholm, K., Thomsen, M., Zaer, H., Orlowski, D., Mikkelsen, T. W., Glud, AN., Nielsen, E. H. T., Schacht, A. C., Winterdahl, M., Brooks, D. J., Sørensen, J. C. H. & Landau, A. (2022). Spontaneous partial recovery of striatal dopaminergic uptake despite nigral cell loss in asymptomatic MPTP-lesioned female minipigs. NeuroToxicology, 91, 166-176. https://doi.org/10.1016/j.neuro.2022.05.006

Liebenberg, N., Wegener, G., Harvey, B. H. & Brink, C. B. (2010). Investigating the role of protein kinase-G in the antidepressant-like response of sildenafil in combination with muscarinic acetylcholine receptor antagonism. Behavioural Brain Research, 209(1), 137-41. https://doi.org/10.1016/j.bbr.2010.01.032

Liebenberg, N., Wegener, G., Brink, T. & Harvey, B. (2010). The role of protein kinase-G in the antidepressant-like response of sildenafil in combination with muscarinic acetylcholine receptor antagonism. Abstract from Scandinavian College of Neuropsychopharmacology 51st Annual Meeting, Göteborg, Sweden.

Liebenberg, N., Müller, H. K., Fischer, C., Harvey, B. H., Brink, C. B., Elfving, B. & Wegener, G. (2011). An inhibitor of cAMP-dependent protein kinase induces behavioural and neurological antidepressant-like effects in rats. Neuroscience Letters, 498(2), 158-61. https://doi.org/10.1016/j.neulet.2011.05.004

Liebenberg, N., Müller, H. K., Elfving, B. & Wegener, G. (2011). A selective inhibitor of protein kinase A induces behavioural and neurological antidepressant-like effects in rats.

Liebenberg, N., Harvey, B. H., Brand, L., Wegener, G. & Brink, C. B. (2012). Chronic treatment with the phosphodiesterase type 5 inhibitors sildenafil and tadalafil display anxiolytic effects in Flinders Sensitive Line rats. Metabolic Brain Disease, 27(3), 337-340. https://doi.org/10.1007/s11011-012-9284-z

Liebenberg, N., Müller, H. K., Elfving, B. & Wegener, G. (2012). Investigating nitric oxide signalling involvement in the antidepressant action of ketamine.

Liebenberg, N., Müller, H. K., Elfving, B. & Wegener, G. (2012). Is nitric oxide signalling involved in the antidepressant action of ketamine?.

Liebenberg, N., Müller, H. K., Elfving, B. & Wegener, G. (2011). A selective inhibitor of protein kinase A induces behavioural and neurological antidepressant-like effect in rats.

Liebenberg, N., Wegener, G., Brink, C. & Harvey, B. (2010). The role of protein kinase-G in the antidepressant-like response of sildenafil in combination with muscarinic acetylcholine receptor antagonism.

Liebenberg, N., Brink, C., Brand, L. & Harvey, B. (2008). Antidepressant-like properties of sildenafil in a genetic rat model of depression: Role of cholinergic cGMP-interactions.

Liebenberg, N., Harvey, B. H., Brand, L. & Brink, C. B. (2010). Antidepressant-like properties of phosphodiesterase type 5 inhibitors and cholinergic dependency in a genetic rat model of depression. Behavioural Pharmacology, 21(5-6), 540-7. https://doi.org/10.1097/FBP.0b013e32833befe5

Liebenberg, N., Muller, H. K., Elfving, B. & Wegener, G. (2012). Investigating altered nitric oxide signalling as an up-stream mediator of the antidepressant action of ketamine. Acta Neuropsychiatrica, 24, 32. http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L70760158 http://dx.doi.org/10.1111/j.1601-5215.2012.00665.x http://wx7cf7zp2h.search.serialssolutions.com?sid=EMBASE&issn=09242708&id=doi:10.1111%2Fj.1601-5215.2012.00665.x&atitle=Investigating+altered+nitric+oxide+signalling+as+an+up-stream+mediator+of+the+antidepressant+action+of+ketamine&stitle=Acta+Neuropsychiatr.&title=Acta+Neuropsychiatrica&volume=24&issue=&spage=32&epage=&aulast=Liebenberg&aufirst=Nico&auinit=N.&aufull=Liebenberg+N.&coden=&isbn=&pages=32-&date=2012&auinit1=N&auinitm=

Liebenberg, N., Joca, S. & Wegener, G. (2014). Nitric oxide involvement in the antidepressant-like effect of ketamine in the Flinders sensitive line rat model of depression. Acta Neuropsychiatrica, 1-7. https://doi.org/10.1017/neu.2014.39

Liebenberg, N., Jensen, E., Larsen, E. R., Kousholt, B. S., Pereira, V. S., Fischer, C. W. & Wegener, G. (2018). A Preclinical Study of Casein Glycomacropeptide as a Dietary Intervention for Acute Mania. International Journal of Neuropsychopharmacology, 21(5), 473-484. https://doi.org/10.1093/ijnp/pyy012

Liebenberg, N. (2010). The inhibition of phosphodiesterase type 5 as a novel target for antidepressant action.

Licht, R. W., Larsen, J. O., Smith, D. & Brændgaard, H. (2003). Chronic lithium treatment with or without haloperidol fails to affect the morphology of the rat cerebellum. European Neuropsychopharmacology, 13(3), 173-176. https://doi.org/10.1016/S0924-977X(03)00003-8

Licht, C. L., Marcussen, A. B., Wegener, G., Overstreet, D. H., Aznar, S. & Knudsen, G. M. (2009). The brain 5-HT4 receptor binding is down-regulated in the Flinders Sensitive Line depression model and in response to paroxetine administration. Journal of Neurochemistry, 109(5), 1363-74.

Displaying results 1151 to 1200 out of 2483

Revised 11.09.2025

Karen Jul Madsen